VAX-ID®: An innovative solution for reliable intradermal drug delivery
VAX-ID® is an award-winning patented intradermal drug delivery device with a high ease of use. It is suited for standardized, accurate and reliable drug delivery intradermally, i.e. in the dermal layer of the skin.
Interestingly, intradermal injection using a lower dose can induce a non-inferior or even superior immune response compared to subcutaneous and intramuscular injections using a full dose. Consequently, intradermal vaccination has the potential to save doses, reduce the cost of vaccines, increase vaccine availability, and make vaccination more effective.
An intradermal injection using VAX-ID is performed perpendicular to the skin by a healthcare professional. VAX-ID contains a short and thin, almost invisible needle. Therefore, it is considered an advantage for people with needle phobia and make people feel more at ease during the injection. Additionally, the device is very easy to use.
Developed by a multidisciplinary team, VAX-ID® allows for
- Accurate injection at a predefined penetration depth
- Dose sparing
- Activation protection and needle-stick injury prevention
- Low in pain and no needle phobia
- Easy to use, potentially leading to self-administration
- User independent
VAX-ID device platform
VAX-ID® can be preconfigured with a 32G, 30G, or 27G needle with a penetration depth of 0.85, 1.00mm and 1.2mm, respectively. The devices allow for delivery of small volumes (0.05cc – 0.2cc per injection). Importantly, the penetration depth of the needle has been predefined based on skin thickness evaluations executed in both adults and children (Van Mulder et al. 2017 and 2020)
Interested in our solutions?
Contact our commercial team!